BEIJING, May 10, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it is scheduled to present at the following investor conferences:
The Company will present at the 16th CLSA China Forum, to be held from May 16 through 18, 2011 at the Grand Hyatt Hotel in Beijing. Management will be available for meetings throughout the conference.
The Company will also present at the J.P. Morgan's 7th Annual China Conference, to be held from June 1 through 3, 2011 at the Grand Hyatt Hotel in Beijing. Management will be available for meetings throughout the conference.
For more information regarding these two conferences, please contact your respective institutional sales representative.
About Concord MedicalConcord Medical operates the largest network of radiotherapy and diagnostic imaging centers in China in terms of revenues and the total number of centers in operation per available statistics. As of December 31, 2010, the Company operated a network of 119 centers with 66 hospital partners, spanning 44 cities and 24 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipments and manages the daily operations of these centers located on its hospital partners' premises. The Company also provides ongoing training to doctors and other medical personnel in its network of centers to ensure a high level of clinical care for patients.
Safe Harbor StatementThis press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should" and "will" and similar expressions. These forward looking statements are based upon management's current views and expectations with respect to future events and are not a guarantee of future performance. Furthermore, these statements are, by their nature, subject to a number of risks and uncertainties that could cause actual performance and results to differ materially from those discussed in the forward-looking statements as a result of a number of factors. Such factors include: the number of new radiotherapy and diagnostic imaging centers opened; the increase in the number of patients in existing centers; the establishment of specialty cancer hospitals; changes in the healthcare industry in China, including changes in the healthcare policies and regulations of the PRC government; and technological or therapeutic changes affecting the field of cancer treatment and diagnostic imaging. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.Investor and Media ContactsChinaTony TianConcord Medical Services+86-10-5957-5287Tony.Tian@concordmedical.comLilian WongBrunswick Group, LLC+86-10-5960-8600 firstname.lastname@example.orgUnited StatesCindy ZhengBrunswick Group, LLCemail@example.com
|SOURCE Concord Medical Services Holdings Limited|
Copyright©2010 PR Newswire.
All rights reserved